.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Dow
Accenture
Argus Health
Harvard Business School
Colorcon
Queensland Health
Julphar
McKesson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Potassium chloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for potassium chloride and what is the scope of potassium chloride patent protection?

Potassium chloride
is the generic ingredient in thirty-nine branded drugs marketed by Savage Labs, Upsher-smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Anchen Pharms, Glenmark Pharms Ltd, Kremers Urban Pharms, Lupin Ltd, Novel Labs Inc, Paddock Llc, PII, Teva, Tris Pharma Inc, Pharma Res Software, Kv Pharm, Abraxis Pharm, Akorn, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Pharma Serve Ny, Watson Labs, Icu Medical Inc, Genus Lifesciences, Future Pak, Abbvie, Apothecon, Copley Pharm, Mylan Pharms Inc, Schering, Sigmapharm Labs Llc, and Novartis, and is included in eighty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are two hundred and thirty-two drug master file entries for potassium chloride. Seventy-five suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for potassium chloride

Tentative approvals for POTASSIUM CHLORIDE

Applicant Application No. Strength Dosage Form
u► Subscribe20MEQTablet; Oral
u► Subscribe10MEQTablet, Extended Release; Oral
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter HlthcarePOTASSIUM CHLORIDEpotassium chlorideINJECTABLE;INJECTION080203-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ScheringPOTASSIUM CHLORIDEpotassium chlorideTABLET, EXTENDED RELEASE;ORAL019439-002Jun 13, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Abraxis PharmPOTASSIUM CHLORIDEpotassium chlorideINJECTABLE;INJECTION086714-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
B BraunPOTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERpotassium chloride; sodium chlorideINJECTABLE;INJECTION019708-001Sep 29, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Lupin LtdPOTASSIUM CHLORIDEpotassium chlorideCAPSULE, EXTENDED RELEASE;ORAL203002-002Dec 18, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsKLOR-CONpotassium chlorideTABLET, EXTENDED RELEASE;ORAL019123-002Apr 17, 1986AB2RXYesYes► Subscribe► Subscribe► Subscribe
Novel Labs IncPOTASSIUM CHLORIDEpotassium chlorideCAPSULE, EXTENDED RELEASE;ORAL204828-001Aug 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
LillyPOTASSIUM CHLORIDEpotassium chlorideINJECTABLE;INJECTION007865-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncPOTASSIUM CHLORIDEpotassium chlorideTABLET, EXTENDED RELEASE;ORAL204662-001Aug 21, 2014AB2RXNoNo► Subscribe► Subscribe► Subscribe
Watson LabsPOTASSIUM CHLORIDEpotassium chlorideINJECTABLE;INJECTION086208-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: potassium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ScheringPOTASSIUM CHLORIDEpotassium chlorideTABLET, EXTENDED RELEASE;ORAL019439-002Jun 13, 1986► Subscribe► Subscribe
Nesher PharmsMICRO-Kpotassium chlorideCAPSULE, EXTENDED RELEASE;ORAL018238-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
ScheringPOTASSIUM CHLORIDEpotassium chlorideTABLET, EXTENDED RELEASE;ORAL019439-001Jun 13, 1986► Subscribe► Subscribe
ApotheconKLOTRIXpotassium chlorideTABLET, EXTENDED RELEASE;ORAL017850-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Kv PharmMICRO-K LSpotassium chlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL019561-003Aug 26, 1988► Subscribe► Subscribe
Nesher PharmsMICRO-K 10potassium chlorideCAPSULE, EXTENDED RELEASE;ORAL018238-002May 14, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Medtronic
Teva
Julphar
Healthtrust
Citi
Johnson and Johnson
Merck
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot